BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = 'Beta-3 adrenergic receptor' and Ligand = 'BDBM484062'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Beta-3 adrenergic receptor


(Homo sapiens (Human))
BDBM484062
PNG
((S)-1-((S)-8-(4'-((tert- butylamino(methyl) biphen...)
Show SMILES CC(C)(C)NCc1ccc(cc1)-c1cccc(c1)S(=O)(=O)N1CCC2(C[C@@H](CO2)NC[C@H](O)COc2cccc(c2)S(=O)(=O)C2(CO)CC2)CC1 |r|
Show InChI InChI=1S/C38H51N3O8S2/c1-36(2,3)40-23-28-10-12-29(13-11-28)30-6-4-9-35(20-30)51(46,47)41-18-16-37(17-19-41)22-31(25-49-37)39-24-32(43)26-48-33-7-5-8-34(21-33)50(44,45)38(27-42)14-15-38/h4-13,20-21,31-32,39-40,42-43H,14-19,22-27H2,1-3H3/t31-,32-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 3.17E+4n/an/an/an/an/an/a



Arena Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds were dissolved and serially diluted (5-fold) in DMSO to generate a 10-point dose response stock. The stock was then diluted 100-fold in ass...


US Patent US10927123 (2021)


BindingDB Entry DOI: 10.7270/Q2D221QM
More data for this
Ligand-Target Pair